Clinical trials
Candidiasis clinical trials
Below are recruiting candidiasis clinical trials, each written for real people, not researchers. We’re tracking 23 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05367089RecruitingPhase 3
Honey treatment for frequent vaginal yeast infections
This Phase 3 study tests a medical-grade honey product (L-Mesitran) to reduce symptoms from recurrent vaginal yeast infections. If you have frequent episodes, the honey treatment may help lower symptom flare-ups compared with usual care.
HeerlenAges 18 years+ - NCT06456151Recruiting
Candida infection in critically ill patients study
This study looks at patients in the intensive care unit who have a new infection with Candida (a type of fungus) despite taking strong antibiotics. It aims to better understand and diagnose these serious infections.
Ostrava, Moravian-Silesian RegionAges 1 year+ - NCT06194201RecruitingPhase 2
Study of HRS9432 for blood or organ yeast infection
This trial tests a new antifungal drug, HRS9432, for patients with candidemia (a yeast infection in the blood) or invasive candidiasis (yeast infection in organs). It aims to see if the drug is safe and works well for these serious infections.
Hengyang, HunanAges 18 years+ - NCT05421858RecruitingPhase 3
Study drug for adults with bloodstream or deep Candida infection
This Phase 3 trial tests fosmanogepix to treat adults with candidemia (Candida in the bloodstream) and/or invasive candidiasis (a deep Candida infection). It looks at whether the medicine is effective and safe, and whether it helps the infection improve when doctors also manage the infection source.
Birmingham, AlabamaAges 18 years+ - NCT05398809RecruitingPhase 2
Ruxolitinib for hair regrowth in APECED-related alopecia areata
This Phase 2 study tests ruxolitinib to see if it safely helps regrow hair in people whose alopecia areata is linked to APECED (a rare immune condition). You may qualify if you have significant scalp hair loss for at least 6 months and haven’t had regrowth with other treatments.
Bethesda, MarylandAges 12–75 - NCT05908682Recruiting
Study of ibrexafungerp safety during pregnancy
This study looks at what happens when ibrexafungerp is taken during pregnancy, including outcomes for the baby. You may join if you were exposed to this medicine during pregnancy (or very close to conception) and you agree to share information and complete study follow-up.
New Delhi, Vasant ViharAges birth+ - NCT06480604Recruiting
Probiotic for yeast infection prevention
This trial tests if taking a multi-strain probiotic daily can prevent repeat yeast infections in women who have had at least three infections in the past year.
Vadodara, GujaratAges 18–50 - NCT06983041Recruiting
Vaginal cooling device for yeast infection treatment
This trial tests a new vaginal cooling device to treat yeast infections. It may help relieve symptoms like itching, burning, or irritation without medication.
Jacksonville, FloridaAges 22–49 - NCT07603895Recruiting
Probiotic treatment for yeast infections
This study tests whether a probiotic product (good bacteria) can help treat vulvovaginal yeast infections alongside standard care. You'll use the probiotic for a set period and report how your symptoms improve.
Torrevieja, AlicanteAges Any age - NCT01386437Recruiting
Study immune problems and fungal infections
This study looks at how immune system problems relate to fungal infections, using medical records and lab tests on blood and tissue. It may help researchers understand the cause of these infections—especially for people with inherited immune conditions—and improve future care.
Bethesda, MarylandAges 1 day–99 years - NCT07607470Recruiting
Vaginal Health Symptom Study with New Testing Method
This study tests a new way to diagnose vaginal infections by collecting samples from the vagina. If you have symptoms like unusual discharge, itching, burning, or odor, this research may help improve how doctors identify what's causing your discomfort.
North Miami, FloridaAges 18 years+ - NCT03580733RecruitingPhase 3
Caspofungin vs placebo for yeast infection in the belly (ICU)
This Phase 3 trial studies whether caspofungin (an antifungal medicine) helps treat suspected or confirmed yeast (candidiasis) infections inside the abdomen in ICU patients after surgery. You would either receive caspofungin or a placebo, and the goal is to see which option works better and is safe.
AmiensAges 18 years+ - NCT03828773Recruiting
Azole antifungal prevention for leukemia during low white blood counts
This trial tests whether using a targeted antifungal medicine (aimed at PTX3) can better prevent serious fungal infections in adults with AML or a related bone marrow disease who will have very low neutrophils. It may help lower the risk of dangerous infections during intensive chemotherapy hospital stays.
Ghent, BelgiumAges 18 years+ - NCT05079711Recruiting
Compare a vaginal yeast test for women with symptoms
This study compares how well a new vaginal yeast (Candida) test matches a standard yeast culture test. It may help clinicians choose the most accurate, convenient way to tell whether vaginal symptoms are caused by yeast.
Fort Bragg, North CarolinaAges 18 years+ - NCT05753813RecruitingEarly Phase 1
Study lactic acid gel to change vaginal germs
This early study tests whether placing a lactic acid gel inside the vagina can change the vaginal “microbiome,” the mix of germs, to help reduce repeat BV or yeast infections. You may join if you’ve had at least two recent episodes that needed treatment.
Honolulu, HawaiiAges 18–54 - NCT05761197Recruiting
Study of mouth yeast infection and a preventive treatment
This trial studies children ages 9–15 months and looks at oropharyngeal yeast infection in the mouth (often called “OPC”). It may help researchers understand how to prevent or manage this condition.
Philadelphia, PennsylvaniaAges 9 months–1.3 years - NCT05763251Recruiting
Shorter antifungal treatment for yeast bloodstream infection in children
This trial compares shorter vs longer treatment for children with an uncomplicated yeast (Candida) bloodstream infection once blood cultures are clear. It may help reduce medicine exposure while keeping the infection under control.
Birmingham, AlabamaAges 4 months+ - NCT06835361RecruitingPhase 2/Phase 3
Comparing two yeast infection treatments for women
This trial tests if a new combination vaginal suppository works better than the standard one for women with yeast infections. It aims to see if adding lactulose to clotrimazole helps clear the infection faster or more completely.
Minsk, Minsk CityAges 18–60 - NCT07093203Recruiting
Rezafungin for fungal infection in the belly
This trial tests how well rezafungin, an antifungal medicine, spreads in belly fluid when given during surgery for a suspected fungal infection in the abdomen. It aims to see if it's a good treatment option for patients needing abdominal surgery.
Vandœuvre-lès-Nancy, LorraineAges 18 years+ - NCT07202598RecruitingPhase 2
Testing emapalumab for gut inflammation in APECED
This trial tests a drug called emapalumab to treat chronic gut inflammation (enteritis) in people with APECED, a rare immune disorder. It aims to see if the drug can help when other treatments haven't worked.
Bethesda, MarylandAges 2–75 - NCT07234786Recruiting
Vaginal gel for treating and preventing vaginal infections
This trial tests a vaginal gel to treat and prevent common vaginal infections like yeast infections (VVC) and bacterial vaginosis (BV). It may help if you currently have symptoms like itching, discharge, or odor.
Quatre BornesAges 18 years+ - NCT07521137RecruitingPhase 2
Biweekly occidiofungin for recurring yeast infections
This study tests occidiofungin, a new antifungal medication inserted into the vagina twice a week to prevent recurring yeast infections (vulvovaginal candidiasis). The goal is to see if this treatment can stop yeast infections from coming back.
Birmingham, AlabamaAges 18–65 - NCT06472765Enrolling by invitation
Study of the Vaginal Ecosystem in Healthy Women
This study looks at the natural balance of bacteria and other factors in the vagina of healthy women. It aims to learn more about what a healthy vaginal ecosystem looks like.
Fullerton, CaliforniaAges 18–89
Hear when a new Candidiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for candidiasis?
- Yes. Clin2 currently lists 23 recruiting candidiasis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a candidiasis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a candidiasis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.